According to our findings, levels of HCC-related serum markers (CA199, FucAFP, ALD-A, and AFu) were obviously elevated in HCC patients, and miR-122/148a expression showed a negative correlation with levels of these indexes. The gene discussed is ALDOA; the disease is hepatocellular carcinoma.